A recessive PRDM13 mutation results in congenital hypogonadotropic hypogonadism and cerebellar hypoplasia
Authors:
- Danielle E. WhittakerDanielle E. Whittaker
- Roberto OleariRORoberto Oleari
- Louise C. GregoryLGLouise C. Gregory
- Hywel J. WilliamsHWHywel J. Williams
- John G. TorpianoJTJohn G. Torpiano
- Nancy FormosaNFNancy Formosa
- Mario J. CachiaMCMario J. Cachia
- Daniel FieldDFDaniel Field
- Antonella LettieriALAntonella Lettieri
- Louise A. OcakaLOLouise A. Ocaka
- Alyssa J.J. PaganoniAlyssa J.J. Paganoni
Open Access
- 15 December 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 131 (24)
Abstract
The positive regulatory (PR) domain containing 13 (PRDM13) putative chromatin modifier and transcriptional regulator functions downstream of the transcription factor PTF1A, which controls GABAergic fate in the spinal cord and neurogenesis in the hypothalamus. Here, we report a recessive syndrome associated with PRDM13 mutation. Patients exhibited intellectual disability, ataxia with cerebellar hypoplasia, scoliosis, and delayed puberty with congenital hypogonadotropic hypogonadism (CHH). Expression studies revealed Prdm13/PRDM13 transcripts in the developing hypothalamus and cerebellum in mouse and human. An analysis of hypothalamus and cerebellum development in mice homozygous for a Prdm13 mutant allele revealed a significant reduction in the number of Kisspeptin (Kiss1) neurons in the hypothalamus and PAX2+ progenitors emerging from the cerebellar ventricular zone. The latter was accompanied by ectopic expression of the glutamatergic lineage marker TLX3. Prdm13-deficient mice displayed cerebellar hypoplasia and normal gonadal structure, but delayed pubertal onset. Together, these findings identify PRDM13 as a critical regulator of GABAergic cell fate in the cerebellum and of hypothalamic kisspeptin neuron development, providing a mechanistic explanation for the cooccurrence of CHH and cerebellar hypoplasia in this syndrome. To our knowledge, this is the first evidence linking disrupted PRDM13-mediated regulation of Kiss1 neurons to CHH in humans.Keywords
All Related Versions
Funding Information
- EMBO (7950)
- Wellcome Trust (WT096385MA)
- Medical Research Foundation (535963)
- Great Ormond Street Hospital Charity (V2218)
- Italian Minstry of Health (GR-2016-02362389)
- Japan Society for the Promotion of Science and The Takeda Science Foundation (18H02593)
- N/A (N/A)
This publication has 75 references indexed in Scilit:
- Ataxia, Dementia, and Hypogonadotropism Caused by Disordered UbiquitinationNew England Journal of Medicine, 2013
- PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional RegulationBiology, 2013
- Recessive Mutations in POLR3B, Encoding the Second Largest Subunit of Pol III, Cause a Rare Hypomyelinating LeukodystrophyThe American Journal of Human Genetics, 2011
- Mutations of POLR3A Encoding a Catalytic Subunit of RNA Polymerase Pol III Cause a Recessive Hypomyelinating LeukodystrophyThe American Journal of Human Genetics, 2011
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- Characterization of Kiss1 neurons using transgenic mouse modelsNeuroscience, 2011
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Synaptic inhibition of Purkinje cells mediates consolidation of vestibulo-cerebellar motor learningNature Neuroscience, 2009
- The Role of the Cerebellum in SchizophreniaBiological Psychiatry, 2008
- Cerebellar GABAergic progenitors adopt an external granule cell-like phenotype in the absence of Ptf1a transcription factor expressionProceedings of the National Academy of Sciences, 2007